A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping

Affiliations

¹ Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. yzou19@jhmi.edu.
² Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
⁴ Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
⁵ Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁶ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.

Ying S Zou et al. Blood Cancer J. 2024.

. 2024 May 3;14(1):78.

doi: 10.1038/s41408-024-01059-x.

¹ Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. yzou19@jhmi.edu.
² Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
³ Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
⁴ Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
⁵ Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
⁶ Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

1. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046–60. doi: 10.1056/NEJMra1011442. - DOI - PubMed
1. Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327:464–77. doi: 10.1001/jama.2022.0003. - DOI - PubMed
1. Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:1086–107. doi: 10.1002/ajh.26590. - DOI - PMC - PubMed
1. Palumbo A, Avet-Loiseau H, Oliva S, Lokhorst H, Goldschmidt H, Rosinol L, et al. Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol. 2015;33:2863–9. doi: 10.1200/JCO.2015.61.2267. - DOI - PMC - PubMed
1. Rustad EH, Yellapantula VD, Glodzik D, Maclachlan KH, Diamond B, Boyle EM, et al. Revealing the impact of structural variants in multiple myeloma. Blood Cancer Discov. 2020;1:258–73. doi: 10.1158/2643-3230.BCD-20-0132. - DOI - PMC - PubMed